Protara Therapeutics Inc’s filing revealed that its 10% Owner Opaleye Management Inc. unloaded Company’s shares for reported $27828.0 on Jul 16 ’24. In the deal valued at $2.44 per share,11,396 shares were sold. As a result of this transaction, Opaleye Management Inc. now holds 56,500 shares worth roughly $0.12 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Opaleye Management Inc. sold 47,993 shares, generating $115,346 in total proceeds. Upon selling the shares at $2.40, the 10% Owner now owns 60,000 shares.
Before that, Opaleye Management Inc. sold 18,061 shares. Protara Therapeutics Inc shares valued at $41,685 were divested by the 10% Owner at a price of $2.31 per share. As a result of the transaction, Opaleye Management Inc. now holds 75,000 shares, worth roughly $0.17 million.
A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Oppenheimer began covering TARA with “an Outperform” recommendation on February 17, 2021. Cowen started covering the stock on October 19, 2020. It rated TARA as “an Outperform”.
Price Performance Review of TARA
On Tuesday, Protara Therapeutics Inc [NASDAQ:TARA] saw its stock jump 3.29% to $2.20. Over the last five days, the stock has gained 15.18%. Protara Therapeutics Inc shares have risen nearly 17.33% since the year began. Nevertheless, the stocks have fallen -3.51% over the past one year. While a 52-week high of $5.24 was reached on 04/05/24, a 52-week low of $1.04 was recorded on 08/12/24. SMA at 50 days reached $2.22, while 200 days put it at $2.58.
Levels Of Support And Resistance For TARA Stock
The 24-hour chart illustrates a support level at 2.09, which if violated will result in even more drops to 1.99. On the upside, there is a resistance level at 2.30. A further resistance level may holdings at 2.41. The Relative Strength Index (RSI) on the 14-day chart is 54.36, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.10, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 19.23%. Stochastics%K at 64.01% indicates the stock is a holding.
How much short interest is there in Protara Therapeutics Inc?
A steep rise in short interest was recorded in Protara Therapeutics Inc stocks on 2024-07-31, dropping by 31208.0 shares to a total of 1.74 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 1.77 million shares. There was a decline of -1.8%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on July 29, 2020 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
